Clinical Genetics Branch Eligibility Screening Survey | MicrobiomeTrials← Back to trialsNCT07005297
Clinical Genetics Branch Eligibility Screening Survey
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2035-01-01
Enrollment target: 1,000 participants Locations- National Cancer Institute, Rockville, Maryland, United States
Other microbiome trials you might be interested in
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IVMelanoma Stage III
In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therape…
Orange, United StatesEst. completion Dec 31, 2027
MelanomaNon Small Cell Lung CancerSolid TumorRare CancersHigh Grade Glioma
This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis…
Scottsdale, United StatesEst. completion Dec 28, 2032